Atlanta Consulting Group Advisors LLC Makes New $267,000 Investment in Danaher Co. (NYSE:DHR)

Atlanta Consulting Group Advisors LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 959 shares of the conglomerate’s stock, valued at approximately $267,000.

Several other hedge funds also recently made changes to their positions in DHR. Rockport Wealth LLC acquired a new stake in shares of Danaher during the 1st quarter valued at $516,000. O Shaughnessy Asset Management LLC boosted its position in shares of Danaher by 26.0% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 43,730 shares of the conglomerate’s stock valued at $10,920,000 after purchasing an additional 9,031 shares during the period. PYA Waltman Capital LLC increased its stake in Danaher by 10.0% in the 1st quarter. PYA Waltman Capital LLC now owns 32,429 shares of the conglomerate’s stock worth $8,098,000 after purchasing an additional 2,935 shares in the last quarter. Lake Street Advisors Group LLC increased its stake in Danaher by 50.3% in the 1st quarter. Lake Street Advisors Group LLC now owns 6,211 shares of the conglomerate’s stock worth $1,553,000 after purchasing an additional 2,079 shares in the last quarter. Finally, Puzo Michael J raised its holdings in Danaher by 9.0% during the 1st quarter. Puzo Michael J now owns 45,993 shares of the conglomerate’s stock worth $11,485,000 after buying an additional 3,788 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Stifel Nicolaus lifted their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada lowered their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. UBS Group reduced their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Raymond James lowered their price target on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Finally, The Goldman Sachs Group increased their price objective on Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $287.16.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Down 3.7 %

Danaher stock opened at $230.50 on Monday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $166.48 billion, a P/E ratio of 43.99, a P/E/G ratio of 4.24 and a beta of 0.85. The firm’s fifty day simple moving average is $262.20 and its 200-day simple moving average is $260.57. Danaher Co. has a 1-year low of $206.30 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the prior year, the business earned $2.02 earnings per share. The company’s revenue was up 3.1% on a year-over-year basis. Sell-side analysts forecast that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.47%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.